Introducing the Concept of Hypertensive Heart Disease to Improve Hypertensive Left Ventricular Hypertrophy

Current Vascular Pharmacology · Published 2025-01-24 · DOI 10.2174/0115701611351415241212092014

Authors being retrieved — see the publisher record. https://doi.org/10.2174/0115701611351415241212092014

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• Refractory arterial hypertension: important, but suboptimally characterized · Current Medical Research and Opinion · 2026 · Cites or is cited by this article
• Is the Cardiovascular Risk Increased in Patients with Isolated SystolicHypertension and Anemia? · Current Vascular Pharmacology · 2026 · Same journal
• Comparison of Clinical Outcomes between Newly Diagnosed and Pre-Existing Diabetes Mellitus Patients after Acute Coronary Syndrome · Current Vascular Pharmacology · 2025 · Same journal
• Clinical Predictors of Warfarin Response Among Patients with Atrial Fibrillation: Evidence from the Middle Eastern JoFib Study · Current Vascular Pharmacology · 2025 · Same journal
• Glucagon-like Peptide-1 Receptor Agonists: Additional Improvement of Erectile Dysfunction in Type 2 Diabetes · Current Vascular Pharmacology · 2025 · Same journal
• Postprandial Triglycerides and Residual Cardiovascular Risk: RethinkingLipid-Lowering Strategies · Current Vascular Pharmacology · 2026 · Same journal
• PCSK9: Its Role in Lipid Metabolism and as a Novel Target for the Treatment of Metabolic Kidney Disease · Current Vascular Pharmacology · 2025 · Same journal
• Advances in Drug-Eluting Angioplasty Balloon Coatings, Clinical Implications and Future Directions: A Mini Review · Current Vascular Pharmacology · 2025 · Same journal
• Cardiovascular Risks of Electronic Cigarettes: Mechanisms, Evidence, and Research Gaps · Current Vascular Pharmacology · 2026 · Same journal
• Significant Stagnancy in the Search and Use of New Antiarrhythmic Agents With Some Recent Beams of Hope · Current Vascular Pharmacology · 2025 · Same journal